Company: INDP
Filing Date: 2025-07-29
Form Type: 8-K
Source: 0001641172-25-021377
Chunk: 2

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-07-29
Form: 8-K
Item: Item 5.07
Chunk 2
---
Item
5.07. Submission of Matters to a Vote of Security Holders.

On
July 25, 2025, the Company held a special meeting of shareholders (the “ Special Meeting”) to consider two proposals in connection
with the Private Placement. A total of 236,794 shares of the Company’s Common Stock were present in person or represented
by proxy at the Special Meeting, representing approximately 41.35% of the Company’s outstanding Common Stock as of the June 16,
2025 record date, which total constituted a quorum for the Special Meeting in accordance with the Company’s bylaws.

The
following are the voting results for the proposals considered and voted upon at the Special Meeting, each of which were described in
the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission
on June 23, 2025.

Proposal
1

  Votes FOR                   Votes AGAINST                 Votes ABSTAINED                 Broker Non-Votes  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────
                 225,534                         9,984                           1,276                        

Proposal
2.

  Votes FOR                   Votes AGAINST                  Votes ABSTAINED                 Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
                 225,161                         10,352                           1,281                        

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
July 29,2025